A small startup pharmaceutical company is at an early stage in the development of a very interesting diabetes treatment .
Sirtris Pharmaceuticals, who have been in the media in the last few years for their inventio, have created a diabetes drug that can mimic the influence of diet and exercise using a daily pill.
The diabetic drug, known as SRT501, is in first-stage human clinical trials. The drug apparently activates the cellular mechanism that are triggered by exercise or a low-calorie diet. The drug could therefore help diabetics to control their disease, and even increase lifespan amongst patients.
Before the Sirtris drug gets any close to being in general release, numerous clinical trials are necessary. The drug could also have a role to play in aging-related diseases such as cancer . The drug could potentially allow diabetics to eat what they like whilst still getting health benefits of a good diet and regular exercise.

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Coronavirus: UK instructed to stay at home this weekend

Health Secretary Matt Hancock has said that staying at home this weekend…

Public Health England considers low carb approach for type 2 diabetes

The low carb approach is being considered by the government to be…

Twice daily dairy intakes could reduce type 2 diabetes risk

Eating cheese, yoghurt or eggs twice a day could help lower the…